First humans test potential COVID-Fighting drug
NCT ID NCT06965751
Summary
This is the first study in humans to test a new drug called PDI204, which is being developed to treat or prevent COVID-19. Researchers want to see if it's safe and how the body processes it. The study involves 32 healthy volunteers who will receive either the drug or a placebo as a single injection or IV dose, and then be monitored for side effects for about 3 months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nucleus Network
Melbourne, Victoria, 3004, Australia
Conditions
Explore the condition pages connected to this study.